CHICAGO–(BUSINESS WIRE)–The Society for Vascular Surgery® Vascular Quality Initiative® (SVS VQI), a nonprofit organization dedicated to improving the quality of vascular care within hospitals and outpatient facilities, announces that the Centers for Medicare and Medicaid Services (CMS) has expanded coverage for Transcarotid Artery Revascularization (TCAR) to include standard surgical risk patients within the VQI […]
Coronary/Structural Heart
Fauna Bio’s Comparative Genomics Approach Finds New Compounds for Heart and Lung Diseases
Partnerships with top institutions move leading candidates into pre-clinical evaluation; platform updates enable discovery of new targets EMERYVILLE, Calif., June 14, 2022 /PRNewswire/ — Fauna Bio, a biotechnology company pioneering the fields of comparative, computational and translational genomics, is celebrating its fourth birthday this month with the release of Centaur, a knowledge graph that is […]
HeartLab Unveils Pulse 2.0, An Efficient Cardiology Imaging Platform, at ASE Scientific Sessions 2022
Pulse is a cloud platform for cardiac imaging that streamlines reporting workflows to help cardiologists be more efficient AUCKLAND, New Zealand, June 13, 2022 /PRNewswire/ — HeartLab, the creator of Pulse — a cloud platform to help clinicians streamline reporting workflows — today announced the US launch of Pulse 2.0 at the American Society […]
Genesis Foundation and SBI Foundation together save a 2-month-old baby from heart failure
THANE, India, June 13, 2022 /PRNewswire/ — Two–month–old, Sakshi (name changed) had a hole in her heart called the Aorta Pulmonary Window. With extreme respiratory distress, the child would not have survived infancy if she had not received timely treatment, with financial support from SBI Foundation, through Genesis Foundation. With a weight of 2.9 kilograms, […]
Keros Therapeutics Presents Results from a Preclinical Study of RKER-012 in Pulmonary Arterial Hypertension at the Pulmonary Hypertension Association International Conference and Scientific Sessions
LEXINGTON, Mass., June 13, 2022 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need, today announced results from a preclinical […]
Cytokinetics Announces Additional Data From REDWOOD-HCM Presented at the American Society of Echocardiography 33rd Annual Scientific Sessions
Echocardiographic Data Show Treatment with Aficamten for 10 Weeks Results In Improved Cardiac Structure, Myocardial Relaxation and Mitral Valve Mechanics SOUTH SAN FRANCISCO, Calif., June 13, 2022 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that additional data from a new analysis of REDWOOD-HCM (Randomized Evaluation of Dosing With CK-274 in Obstructive Outflow Disease in HCM) […]
Valbiotis announces the major success of the Phase II HEART clinical study: the patented plant-based active substance TOTUM•070 proves its efficacy against hypercholesterolemia, a cardiovascular risk factor
This randomized, placebo-controlled Phase II clinical study with TOTUM•070 achieved its objective of reducing LDL cholesterol (primary endpoint) and confirmed the very good tolerance of this active substance. As early as 3 months of supplementation, the results showed a significant reduction in blood levels of LDL cholesterol (-13%) and triglycerides […]
Amarin Receives Positive Recommendation from United Kingdom’s (UK) National Institute for Health and Care Excellence (NICE) for Reimbursement of VAZKEPA® (icosapent ethyl)
UK’s NICE issued its draft Final Appraisal Document (FAD) recommending the use of VAZKEPA® (icosapent ethyl) in England and Wales to reduce the risk of cardiovascular (CV) events in adult statin-treated patients at high CV risk who have elevated triglycerides (≥150 mg/dL [≥ 1.7 mmol/L]) and established cardiovascular disease (eCVD) 1,2 Positive […]
Acarix signs additional commercial agreement in US and receives order for CADScor®System in Louisiana.
Acarix continues the US expansion with another commercial partnership now covering Louisiana and parts of Mississippi. This partnership with Bio-Rhythms Inc provides access to cardiology clinics, emergency departments and primary care clinics in geographic areas with high medical need for rapid and cost-effective rule-out of coronary artery disease. Louisiana is among the top 5 US states based on […]
LATE-BREAKING DATA REINFORCE BROAD RANGE OF PATIENTS BENEFIT FROM ABBOTT’S MITRAL AND TRICUSPID HEART VALVE DEVICES
– New results demonstrate MitraClip™ transcatheter edge-to-edge repair (TEER) is effective at treating leaky valves in people with secondary mitral regurgitation (MR) – Data from the first report on patients with a pacemaker lead across the tricuspid valve show TriClip™ and TriClip G4 TEER systems significantly reduce tricuspid regurgitation (TR) […]



